iShares Biotechnology ETF $IBB Stock Acquired by Pictet Asset Management Holding SA

Pictet Asset Management Holding SA lifted its position in iShares Biotechnology ETF (NASDAQ:IBB) by 8.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 59,475 shares of the financial services provider’s stock after buying an additional 4,525 shares during the period. Pictet Asset Management Holding SA owned about 0.11% of iShares Biotechnology ETF worth $12,552,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Bank of America Corp DE increased its position in shares of iShares Biotechnology ETF by 10.8% during the first quarter. Bank of America Corp DE now owns 7,259,501 shares of the financial services provider’s stock valued at $1,225,767,000 after acquiring an additional 707,343 shares in the last quarter. Henshaw Capital LLC bought a new position in iShares Biotechnology ETF in the 1st quarter valued at approximately $20,262,000. MinichMacGregor Wealth Management LLC lifted its position in iShares Biotechnology ETF by 3,323.4% in the 3rd quarter. MinichMacGregor Wealth Management LLC now owns 78,396 shares of the financial services provider’s stock valued at $16,505,000 after acquiring an additional 76,106 shares in the last quarter. Redstone Wealth Management LLC bought a new position in iShares Biotechnology ETF in the 3rd quarter valued at approximately $12,401,000. Finally, The Manufacturers Life Insurance Company lifted its position in iShares Biotechnology ETF by 64.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 101,838 shares of the financial services provider’s stock valued at $19,369,000 after acquiring an additional 39,760 shares in the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 2.2%

Shares of IBB opened at $213.43 on Friday. The business’s fifty day simple moving average is $208.98 and its two-hundred day simple moving average is $186.73. iShares Biotechnology ETF has a 12 month low of $159.68 and a 12 month high of $222.29.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, September 18th. Stockholders of record on Tuesday, September 15th were issued a dividend of $0.0112 per share. The ex-dividend date of this dividend was Tuesday, September 15th. This is a decrease from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.0%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.